secwatch / observer
8-K filed March 19, 2024, 7:59 PM ET ticker HQY CIK 0001428336
earnings confidence high sentiment positive materiality 0.80

HealthEquity FY2024 revenue $999.6M (+16%), net income $55.7M vs loss; Q4 beat; guides FY2025 rev ~$1.15B

HEALTHEQUITY, INC.

2024-FY EPS reported $0.64 revenue$999,587,000

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.99

HEALTHEQUITY, INC. reported the fiscal year ended January 31, 2024 results: revenue $999.6 million, net income $55.7 million, EPS $0.64 per diluted share.

Period
the fiscal year ended January 31, 2024
Revenue
$999.6 million
Net income
$55.7 million
EPS
$0.64 per diluted share
Result
reported results
Exact text from the filing
--- EX-99.1 (EX-99.1) --- HealthEquity Reports Fiscal Year and Fourth Quarter Ended January 31, 2024 Financial Results Highlights of the fiscal year include: • Revenue of $999.6 million, an increase of 16% compared to $861.7 million in FY23. • Net income of $55.7 million, compared to net loss of $26.1 million in FY23, with non-GAAP net income of $195.5 million,
View on SEC.gov
Earnings Releases SEC 8-K Item 2.02 confidence 0.99

HEALTHEQUITY, INC. reported the fourth quarter ended January 31, 2024 results: revenue $262.4 million, net income $26.4 million, EPS $0.30 per diluted share.

Period
the fourth quarter ended January 31, 2024
Revenue
$262.4 million
Net income
$26.4 million
EPS
$0.30 per diluted share
Result
reported results
Exact text from the filing
Revenue for the fourth quarter ended January 31, 2024 was $262.4 million
View on SEC.gov

171 earnings releases filed in the last 30 days. Browse all earnings releases →

HEALTHEQUITY, INC. filing history →

Source: SEC EDGAR
accession 0001428336-24-000009
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.